formation assays were performed as described previously.16 (link) For the initial screening assay, compounds were
tested at the concentrations of 50, 25, 10, 5, and 2.5 μM for
inhibition of biofilm pellicle formation, which was evaluated by eye
following 3 weeks of incubation under low oxygen and 2 weeks of incubation
under aerated conditions. For the assays involving the determination
of the IC50 for biofilm inhibition by
with stationary-phase Mtb with and without two-fold
dilutions of
μM for the more potent compounds,
assay. The plates were sealed in airtight containers and incubated
at 37 °C with 5% CO2. After 3 weeks, the lid of the
container was removed, and the plates were incubated for an additional
3 weeks. At the end of the 6-week treatment, the plates were photographed
and the OD600 through the pellicle at the air/liquid interface
in each well was quantified using a BioTek Synergy H1 Plate reader
to determine pellicle density. In control wells containing tyloxapol,
the procedure was the same but 0.05% tyloxapol was added to each well.